|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net of allowance of $997 and $995 | ||||||||||||||||||||
| Accounts receivable - related party, net of allowance of $0 and $0 | ||||||||||||||||||||
| Contract assets | ||||||||||||||||||||
| Contract assets - related party | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Deferred cost of products sold - related party | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Contract assets | ||||||||||||||||||||
| Deferred cost of products sold, noncurrent - related party | ||||||||||||||||||||
| Restricted cash, noncurrent | ||||||||||||||||||||
| Recoverable taxes from Brazilian government entities | ||||||||||||||||||||
| Right-of-use assets under financing leases, net | ||||||||||||||||||||
| Right-of-use assets under operating leases, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities, Mezzanine Equity and Stockholders' (Deficit) Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued and other current liabilities | ||||||||||||||||||||
| Lease liabilities (Note 2) | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Financing lease liabilities | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Total lease liabilities | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Debt, current portion | ||||||||||||||||||||
| Related party debt, current portion | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net of current portion | ||||||||||||||||||||
| Related party debt, net of current portion | ||||||||||||||||||||
| Lease liabilities, net of current portion (Note 2) | ||||||||||||||||||||
| Lease liabilities, net of current portion | ||||||||||||||||||||
| Financing lease liabilities, net of current portion | ||||||||||||||||||||
| Operating lease liabilities, net of current portion | ||||||||||||||||||||
| Total lease liabilities, net of current portion | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Acquisition-related contingent consideration | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Mezzanine equity: | ||||||||||||||||||||
| Contingently redeemable common stock | ||||||||||||||||||||
| Contingently redeemable common stock | ||||||||||||||||||||
| Total contingently redeemable common stock | ||||||||||||||||||||
| Contingently redeemable noncontrolling interest | ||||||||||||||||||||
| Stockholders’ (deficit) equity: | ||||||||||||||||||||
| Preferred stock - $0.0001 par value, 5,000,000 shares authorized as of December 31, 2022 and 2021; 0 shares issued and outstanding as of December 31, 2022 and 2021 | ||||||||||||||||||||
| Common stock - $0.0001 par value, 550,000,000 shares authorized as of March 31, 2023 and December 31, 2022; 368,524,240 and 364,745,266 shares issued and outstanding as of March 31, 2023 and December 31, 2022 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Amyris, Inc. stockholders’ (deficit) equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total stockholders' (deficit) equity | ||||||||||||||||||||
| Total liabilities, mezzanine equity and stockholders' (deficit) equity | ||||||||||||||||||||
Loading...
